E Hansson1, K Hagberg2, M Cawson3, T H Brodtkorb4. 1. Institute of Health and Care Sciences, Sahlgrenska Academy University of Gothenburg, Medicinaregatan 3, Gothenburg 413 90, Sweden and Department of Orthopaedics, Sahlgrenska University Hospital, Gothenburg 413 45, Sweden. 2. University of Gothenburg, Medicinaregatan 3, Gothenburg 413 90, Sweden and Advanced Reconstruction of Extremities and Department of Prosthetics and Orthotics, Sahlgrenska University Hospital, Gothenburg 413 45, Sweden. 3. RTI Health Solutions, The Pavilion, Towers Business Park, Wilmslow Road, Didsbury, Manchester M20 2LS, UK. 4. RTI Health Solutions, Vällebergsv 9B, Ljungskile 459 30, Sweden.
Abstract
Aims: The aim of this study was to compare the cost-effectiveness of treatment with an osseointegrated percutaneous (OI-) prosthesis and a socket-suspended (S-) prosthesis for patients with a transfemoral amputation. Patients and Methods: A Markov model was developed to estimate the medical costs and changes in quality-adjusted life-years (QALYs) attributable to treatment of unilateral transfemoral amputation over a projected period of 20 years from a healthcare perspective. Data were collected alongside a prospective clinical study of 51 patients followed for two years. Results: OI-prostheses had an incremental cost per QALY gained of €83 374 compared with S-prostheses. The clinical improvement seen with OI-prostheses was reflected in QALYs gained. Results were most sensitive to the utility value for both treatment arms. The impact of an annual decline in utility values of 1%, 2%, and 3%, for patients with S-prostheses resulted in a cost per QALY gained of €37 020, €24 662, and €18 952, respectively, over 20 years. Conclusion: From a healthcare perspective, treatment with an OI-prosthesis results in improved quality of life at a relatively high cost compared with that for S-prosthesis. When patients treated with S-prostheses had a decline in quality of life over time, the cost per QALY gained by OI-prosthesis treatment was considerably reduced. Cite this article: Bone Joint J 2018;100-B:527-34.
Aims: The aim of this study was to compare the cost-effectiveness of treatment with an osseointegrated percutaneous (OI-) prosthesis and a socket-suspended (S-) prosthesis for patients with a transfemoral amputation. Patients and Methods: A Markov model was developed to estimate the medical costs and changes in quality-adjusted life-years (QALYs) attributable to treatment of unilateral transfemoral amputation over a projected period of 20 years from a healthcare perspective. Data were collected alongside a prospective clinical study of 51 patients followed for two years. Results: OI-prostheses had an incremental cost per QALY gained of €83 374 compared with S-prostheses. The clinical improvement seen with OI-prostheses was reflected in QALYs gained. Results were most sensitive to the utility value for both treatment arms. The impact of an annual decline in utility values of 1%, 2%, and 3%, for patients with S-prostheses resulted in a cost per QALY gained of €37 020, €24 662, and €18 952, respectively, over 20 years. Conclusion: From a healthcare perspective, treatment with an OI-prosthesis results in improved quality of life at a relatively high cost compared with that for S-prosthesis. When patients treated with S-prostheses had a decline in quality of life over time, the cost per QALY gained by OI-prosthesis treatment was considerably reduced. Cite this article: Bone Joint J 2018;100-B:527-34.
Authors: Ellen J MacKenzie; Alison Snow Jones; Michael J Bosse; Renan C Castillo; Andrew N Pollak; Lawrence X Webb; Marc F Swiontkowski; James F Kellam; Douglas G Smith; Roy W Sanders; Alan L Jones; Adam J Starr; Mark P McAndrew; Brendan M Patterson; Andrew R Burgess Journal: J Bone Joint Surg Am Date: 2007-08 Impact factor: 5.284
Authors: Anthony M Harris; Peter L Althausen; James Kellam; Michael J Bosse; Renan Castillo Journal: J Orthop Trauma Date: 2009-01 Impact factor: 2.512
Authors: Jason S Hoellwarth; Kevin Tetsworth; John Kendrew; Norbert Venantius Kang; Oscar van Waes; Qutaiba Al-Maawi; Claudia Roberts; Munjed Al Muderis Journal: Bone Joint J Date: 2020-02 Impact factor: 5.082